TSPYL5 and neuroblastoma: The results showed that the decrease in TSPYL5 seriously reduced the viability and increased the apoptosis of NB cells treated with cisplatin, a commonly used chemotherapeutic agent, and the rescue of TSPYL5 expression restored the proliferation and inhibited the apoptosis of cisplatin-treated NB cells (Fig. 2A, B).